Lu Zhang
No. 215, Hepingxi Road
Shijiazhuang, 050000, China
Shijiazhuang, 050000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Let-7f-5p/AIMP1/ZO-1 axis mediates blood-brain barrier dysfunction in neuromyelitis optica spectrum disorders.
Journal: Clinical and experimental immunology
Published: January 02, 2025
BTK and YKL-40 Levels and Their Association with Acute AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
Journal: Molecular neurobiology
Published: April 16, 2024
Interferon Regulatory Factor 5 Gene Polymorphisms and mRNA Expression Levels Are Associated with Neuromyelitis Optica Spectrum Disorder.
Journal: Molecular neurobiology
Published: August 22, 2023
Decreased SIRT1 mRNA expression in peripheral blood mononuclear cells from patients with neuromyelitis optica spectrum disorders.
Journal: Acta neurologica Belgica
Published: February 18, 2023
Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder.
Journal: Multiple sclerosis and related disorders
Published: July 20, 2022
BLK polymorphisms and expression level in neuromyelitis optica spectrum disorder.
Journal: CNS neuroscience & therapeutics
Published: August 04, 2021
Physical, Emotional, Medical, and Socioeconomic Status of Patients With NMOSD: A Cross-Sectional Survey of 123 Cases From a Single Center in North China.
Journal: Frontiers in neurology
Published: July 07, 2021
Efficacy of azathioprine, mycophenolate mofetil, and rituximab in the treatment of neuromyelitis optica spectrum disorder and analysis of prognostic factors.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: March 05, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026